Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Adaptimmune
University of Colorado, Denver
UNC Lineberger Comprehensive Cancer Center
Maastricht Radiation Oncology
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
MacroGenics
Incyte Corporation
Genentech, Inc.
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Cedars-Sinai Medical Center
PureTech
Medical University of South Carolina
UNICANCER
Acepodia Biotech, Inc.
Xencor, Inc.
Cedars-Sinai Medical Center
Celldex Therapeutics
STCube, Inc.
UNICANCER
Apexigen America, Inc.
Emory University
Klus Pharma Inc.
Endocyte
Eastern Cooperative Oncology Group
Fate Therapeutics
Mirati Therapeutics Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
The Netherlands Cancer Institute
Technische Universität Dresden
Boryung Pharmaceutical Co., Ltd
Roswell Park Cancer Institute
Pfizer
Bayer
Incyte Corporation
Five Prime Therapeutics, Inc.
Incyte Corporation
MacroGenics
Weill Medical College of Cornell University
Shionogi Inc.
Wake Forest University Health Sciences
Bayer
Institut Bergonié
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University of Miami